Merck Will Help Manufacture Johnson & Johnson's COVID-19 Vaccine

By Sydney Lupkin

Published March 2, 2021 at 11:30 AM MST

Facebook
Twitter
LinkedIn
Email

Merck traditionally has been a leader in vaccines but has not had success with a COVID-19 vaccine. It's lending a hand to Johnson & Johnson, where production is running significantly behind schedule.

NPR Coronavirus Updates

Facebook
Twitter
LinkedIn
Email

Sydney Lupkin

Sydney Lupkin is the pharmaceuticals correspondent for NPR.

See stories by Sydney Lupkin